Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of XPO1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of XPO1 mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of XPO1 mRNA | affects expression | 21346803
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen results in decreased expression of XPO1 mRNA | decreases expression | 16514628
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of XPO1 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of XPO1 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of XPO1 mRNA | decreases expression | 20382639 19150397 20018196
|
D003345 |
Corticosterone |
Corticosterone results in decreased expression of XPO1 mRNA | decreases expression | 15755911
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of XPO1 mRNA | decreases expression | 16847355 18614847
|
D004958 |
Estradiol |
Estradiol results in increased expression of XPO1 mRNA | increases expression | 16514628
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of XPO1 mRNA | decreases expression | 16514628
|
C038753 |
leptomycin B |
leptomycin B results in decreased activity of XPO1 protein | decreases activity | 14736876 15994771
|
D020849 |
Raloxifene |
Raloxifene results in decreased expression of XPO1 mRNA | decreases expression | 16514628
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of XPO1 mRNA | decreases expression | 20308225
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of XPO1 mRNA | increases expression | 19465110
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of XPO1 mRNA | decreases expression | 18614847
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
8.55 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.55 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.10 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.40 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.73 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.93 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.60 | 17451421 17308373 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.62 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.54 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.95 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.87 | 10982225 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.08 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.26 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.34 | 16456186 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.86 | 11514358 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.41 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.95 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.95 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.76 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.49 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.97 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.97 | 18497071 17289903 17018787 12948864 14630087 16675129 17261762 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
2.97 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.97 | 17261762 17440819 15758505 17595753 15775269 17049068 17952589 17242785 16837676 17893378 15572757 16912660 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.97 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.97 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.61 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.48 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.80 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.19 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
11.40 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
11.40 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
11.40 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
11.40 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
11.40 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
11.40 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
7.59 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.59 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.59 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.08 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.45 | 15775269 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
12.38 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
12.38 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
12.38 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
16.05 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
16.05 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
16.05 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
16.05 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.61 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.19 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.77 | 15668235 16354765 15340226 8697196 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.77 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.63 | 15800139 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.72 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
9.20 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.20 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.45 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.45 | 17551590 16925845 9125849 9224671 10589399 9211117 8800419 14991402 9142499 9664655 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.94 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.94 | 18551238 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.16 | 17474826 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.02 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.02 | 15920148 17451421 17308373 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
12.03 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.03 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
12.03 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.03 | 18713872 12153990 19420014 19416960 11743745 10663392 19370779 11461765 11529661 11287661 11739529 10915739 11421492 12705907 16109766 16781746 11834606 18071297 14986274 19739265 16485898 17906064 12594235 14725611 17522070 16393943 16177239 16081117 10774834 16227642 19085960 15619225 14550746 19164858 12392966 19923254 17562736 2444490 12958197 12540782 15968718 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.03 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.13 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.76 | 11462148 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.87 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.87 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.05 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.05 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
9.42 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
9.42 | 15845917 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
12.58 | 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.58 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.58 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.02 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.07 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.84 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.84 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
3.63 | 17473493 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.66 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.66 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.71 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.70 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.01 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.19 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.19 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.54 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.54 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.54 | 11110106 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.91 | 12621046 16120746 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.06 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.16 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.78 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 8697196 15340226 16354765 16959395 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.63 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.63 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.58 | 16778211 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
5.23 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.23 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
7.11 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.11 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.86 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.97 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.78 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.95 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.95 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
10.05 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
10.05 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
10.05 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.41 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.41 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
12.41 | 15610895 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.50 | 16973256 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.77 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.70 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.08 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.15 | 19075265 12679006 17649720 16331271 16891316 15748426 17361223 17294898 16935935 19642359 16788101 17301526 19029980 16766008 17339181 17217047 17107899 19225113 16140955 16823087 19035177 17712046 17368321 9834237 17506722 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.31 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.44 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.44 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.44 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.63 | 11587558 16610002 19460945 12969438 12587719 16611625 19784758 19014921 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.24 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.41 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.41 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.41 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.74 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.74 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.17 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.30 | 17306315 16712894 15276417 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.30 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
6.34 | 12807724 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.34 | 17203775 16891317 11408345 11807958 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.51 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.78 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.34 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.34 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.58 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.44 | 16940565 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.58 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.44 | 16497877 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.08 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.28 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.58 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.41 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.41 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.11 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.11 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.68 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.75 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
16.39 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
16.39 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
16.39 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.32 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.32 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.87 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
15.18 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
15.18 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
15.18 | 14694615 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.39 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.23 | 17893378 15579764 17823083 15758505 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.88 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.88 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.88 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.59 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.59 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.46 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.21 | 11399792 11896295 11222880 11118676 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.80 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.89 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.10 | 12479363 18247401 16644109 16289102 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.10 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.10 | 16536755 15731164 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.10 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.61 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.81 | 16723453 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.58 | 15770314 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.11 | 16116481 16283617 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.87 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.87 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.44 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.44 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.44 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.80 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.82 | 16837676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.03 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
13.82 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
13.82 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.79 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.23 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
11.96 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
11.96 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
11.96 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
11.96 | 16712894 16452187 11723127 17306315 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.06 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.06 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.98 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.42 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.42 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.64 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.44 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.24 | 16837676 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.07 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.58 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.97 | 16287080 |